| Product Name | Bosentan-13C2, d4 |
| Product Code | DA-B171-13 |
| Chemical name | Bosentan-13C2, d4 |
| Synonyms | 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy-13C2, d4)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide; p-tert-Butyl-N-[6-(2-hydroxyethoxy-13C2, d4)-5-(o-methoxyphenoxy) -2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide; Actelion-13C2, d4; Ro 47-0203-13C2, d4; Ro 47-0203/039-13C2, d4; Tracleer-13C2, d4; |
| Impurity | NA |
| CAS Number | NA |
| Alternate CAS # | NA |
| Molecular form | C2513C2H25D4N5O6S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 557.62 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | aromatics,heterocycles,nucleotides,bases and related reagents,pharmaceutical standards,intermediates,Fine Chemicals,sulphur and selenium compounds,stable isotopes |
| Boiling Point | NA |
| Applications | Bosentan-13C2, d4 is the labeled analogue of Bosentan, a mixed endothelin receptor antagonist; used as a vasodilator. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
